Debarment and ExclusionsorganizationID: NK-bLtnLYmn5W4MsyhfmMQwrV
1756 Pharmacy INC Aka/dba Drug Rich Pharmacy
Primary Source
US NY MED EXCLUSIONS
Coverage
us
Risk Tier
High
Last Updated
2026-07-26
Compliance Profile
"Due Diligence Flag: 1756 Pharmacy INC Aka/dba Drug Rich Pharmacy has records on compliance watchlists (US NY MED EXCLUSIONS). Review obligations before proceeding."
Banking Impact
Records on US NY MED EXCLUSIONS can trigger enhanced due diligence, compliance holds, counterparty review and documentation requests from banks, investors or procurement teams.
Legal Status
The record should be reviewed against the original source list, jurisdiction and date of publication before decisions are made. Escalation may be required for procurement, onboarding or investor diligence.
Official Source Metadata
Source: Debarment and Exclusions| Full Legal Name | 1756 Pharmacy INC Aka/dba Drug Rich Pharmacy |
| Source Records | US NY MED EXCLUSIONS |
| Enforcement Type | Debarment and Exclusions |
| Identifiers | 00017558 |
| Risk Topics | debarment |
Associated Subject Network
" Ključavničarstvo ",servisiranje in Montaža Miran Vertačnik S.p.
"Bruma" Vulkanizerstvo in Prodaja Avtoplaščev Matija Brunskole S.p.
"Centavria" Elektroinštalacije, Posredovanje in Organiziranje Kulturnih Dejavnosti, Posredovanje Pri Prodaji Blaško Goran S.p.
"Centralvod" Antun Đuran S.p.
Compliance Context Review
Independent Risk Assessment
SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.
Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Confidential Review
Export PDFSubscriber Only